Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,685 | 5,165 | 3,082 | 4,443 | 3,116 |
| Other current assets | 13 | 23 | 101 | 0 | 0 |
| TOTAL | $3,968 | $5,464 | $3,353 | $4,749 | $3,572 |
| Non-Current Assets | |||||
| PPE Net | 1,529 | 1,534 | 1,394 | 1,477 | 1,495 |
| Other Non-Current Assets | 102 | 121 | 143 | 178 | 211 |
| TOTAL | $1,631 | $1,656 | $1,537 | $1,655 | $1,706 |
| Total Assets | $5,599 | $7,119 | $4,890 | $6,403 | $5,278 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 220 | 214 | 161 | 109 | 520 |
| Accrued Expenses | 1,097 | 805 | 888 | 832 | 697 |
| TOTAL | $1,414 | $1,119 | $1,149 | $1,041 | $1,317 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4 | 25 | 49 | 72 | 95 |
| TOTAL | $4 | $25 | $49 | $72 | $95 |
| Total Liabilities | $1,417 | $1,144 | $1,198 | $1,113 | $1,412 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,035 | 972 | 454 | 374 | 374 |
| Retained earnings | -43,437 | -41,517 | -40,088 | -38,490 | -36,533 |
| TOTAL | $4,181 | $5,975 | $3,693 | $5,290 | $3,866 |
| Total Liabilities And Equity | $5,599 | $7,119 | $4,890 | $6,403 | $5,278 |